ATCT-07 PHASE 2 STUDY OF MEDI-575, AN ANTI-PLATELET-DERIVED GROWTH FACTOR-α ANTIBODY, IN PATIENTS WITH RECURRENT GLIOBLASTOMA

Eitemau Tebyg

• ATCT-25 LONG-TERM REMISSION OVER 5 YEARS FOR PATIENT WITH RECURRENT GLIOBLASTOMA TREATED WITH CEDIRANIB/LOMUSTINE
  gan: Hu, Jethro, et al.
  Cyhoeddwyd: (2015)
• ATCT-11 RECURRENT GANGLIOGLIOMA TREATED WITH BRAF INHIBITORS
  gan: Chamberlain, Marc
  Cyhoeddwyd: (2015)
• A phase I dose-escalation study of MEDI-575, a PDGFRα monoclonal antibody, in adults with advanced solid tumors
  gan: Becerra, Carlos R., et al.
  Cyhoeddwyd: (2014)
• ATCT-10 HIGH-DOSE CYTARABINE SALVAGE THERAPY FOR RECURRENT PRIMARY CNS LYMPHOMA
  gan: Chamberlain, Marc
  Cyhoeddwyd: (2015)
• ATCT-24 ROLE OF PHOTODYNAMIC THERAPY (PDT) FOR GLIOBLASTOMA
  gan: Nitta, Masayuki, et al.
  Cyhoeddwyd: (2015)